Loading...
Efficacy and safety of immune checkpoint inhibitor monotherapy in elderly patients with non‐small cell lung cancer
The efficacy and safety of immune checkpoint inhibitor (ICI) monotherapy in elderly patients with non‐small cell lung cancer (NSCLC) remain unclear, especially in patients older than 80 years. We retrospectively reviewed the records of 10 patients older than 80 years with NSCLCs treated by ICIs. The...
Na minha lista:
| Udgivet i: | Aging Med (Milton) |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7954839/ https://ncbi.nlm.nih.gov/pubmed/33738379 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/agm2.12147 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|